Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Market Cap

Prelude Therapeutics has a market cap or net worth of $262.27 million as of April 24, 2024. Its market cap has decreased by -31.91% in one year.

• Market Cap: 262.27M
• Enterprise Value: 42.18M
• 1-Year Change: -31.91%
• Ranking: #3444
• Category: Micro-Cap
• Stock Price: $3.87

Market Cap Chart

Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $262.27M, a decrease of -67.49%. That is a compound annual growth rate of -26.95%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	212.50M	0.52%
Apr 22, 2024	211.40M	3.48%
Apr 19, 2024	204.30M	8.15%
Apr 18, 2024	188.90M	-17.73%
Apr 17, 2024	229.60M	-14.87%
Apr 16, 2024	269.70M	-12.77%
Apr 15, 2024	309.20M	0.16%
Apr 12, 2024	308.70M	7.67%
Apr 11, 2024	286.70M	5.44%
Apr 10, 2024	271.90M	-0.80%
Apr 9, 2024	274.10M	6.20%
Apr 8, 2024	258.10M	-
Apr 5, 2024	258.10M	-0.85%
Apr 4, 2024	260.30M	0.42%
Apr 3, 2024	259.20M	2.17%
Apr 2, 2024	253.70M	-1.51%
Apr 1, 2024	257.60M	-1.04%
Mar 28, 2024	260.30M	-0.65%
Mar 27, 2024	262.00M	3.48%
Mar 26, 2024	253.20M	-
Mar 25, 2024	253.20M	-1.90%
Mar 22, 2024	258.10M	-2.49%
Mar 21, 2024	264.70M	-0.41%
Mar 20, 2024	265.80M	-
Mar 19, 2024	265.80M	4.07%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Invivyd	270.63M
Inovio Pharmaceuticals	268.65M
Vanda Pharmaceuticals	266.40M
Metagenomi	263.43M
EDAP TMS	263.07M
Sharecare	261.83M
Pyxis Oncology	261.60M
Nektar Therapeutics	260.74M